Innovation is What is innovation? How does UCB approach innovation? What is UCB’s innovation culture? Innovation is at the centre of everything our R&D colleagues do at UCB, but how we innovate is as unique as our employees and for this reason we asked our researchers to share with you what innovation means to them. So let us show that innovation is a philosophy that’s embedded in everything we do. Encouraging Innovation: UCB's Culture of Connection and Collaboration UCB Innovation in Business, Technology and Science Transformative Partnerships: UCB's Patient-Centric Approach to Advancing Healthcare UCB's Commitment to Innovation in Healthcare Driving Innovation and Impactful Changes at UCB Closing the gap between the scientist and the patient We Are Prioritising Innovation in Healthcare The Transformative Role of Statistics in the Era of Digital Technologies and Big Data Collaboration, Value, and Risk: Vital ingredients for healthcare innovation What does the future hold for clinical trials Innovation in Healthcare: The Power of Collaborations New approaches in epilepsy research Harnessing the power of digital technology to drive innovation Innovation and failure - it’s a healthy relationship Invention vs innovation: the importance of incremental change Key to innovation is an understanding that it’s vital to challenge your thinking Innovation is about how we connect the things that we observe and the science that we do with real needs of patients Culture is critical when creating an environment where innovation thrives UCB drives innovation through having an open and agile mindset and that means being curious UCB – A Home for Innovation What is Innovation? How digital technologies are disrupting drug discovery and development Patient-centred framework informs UCB’s approach to drug development Ensuring innovation meets real-world needs Early patient engagement key for achieving real innovation Using our innovative antibody know-how to enhance the power of nature Understanding diversity’s role in advancing innovation Tiny antibodies could have big potential
